Red Tortoise LLC’s Akero Therapeutics AKRO Stock Holding History

Red Tortoise LLC’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30	Closed	-$1.15K	–	551
2023 Q1	$1.15K	Buy	+30	New	+$1.34K	﹤0.01%	530

Other funds holding AKRO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Red Tortoise LLC's AKRO Position: Q2 2023 in Review

Red Tortoise LLC sold out of Akero Therapeutics (AKRO) in Q2 2023, closing a stake of 30 shares — an estimated $1.15K sold.

Red Tortoise LLC first reported a position in AKRO in Q1 2023 and held it in 1 quarter. The position peaked at $1.15K in Q1 2023. 157 funds tracked by Wall St. Rank hold AKRO as of Q2 2023.

Red Tortoise LLC reported no remaining Akero Therapeutics position as of Q2 2023 after selling out during the quarter.
Red Tortoise LLC sold 30 Akero Therapeutics shares in Q2 2023, an estimated $1.15K.
Red Tortoise LLC first reported a position in Akero Therapeutics in Q1 2023 and held it in 1 quarter.
Red Tortoise LLC's Akero Therapeutics position peaked at $1.15K in Q1 2023.
157 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2023.

Based on Red Tortoise LLC's 13F filing for Q2 2023, filed 26 Jul 2023.